1. Home
  2. NSP vs FOLD Comparison

NSP vs FOLD Comparison

Compare NSP & FOLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NSP
  • FOLD
  • Stock Information
  • Founded
  • NSP 1986
  • FOLD 2002
  • Country
  • NSP United States
  • FOLD United States
  • Employees
  • NSP N/A
  • FOLD N/A
  • Industry
  • NSP Professional Services
  • FOLD Biotechnology: Pharmaceutical Preparations
  • Sector
  • NSP Consumer Discretionary
  • FOLD Health Care
  • Exchange
  • NSP Nasdaq
  • FOLD Nasdaq
  • Market Cap
  • NSP 2.6B
  • FOLD 2.9B
  • IPO Year
  • NSP 1997
  • FOLD 2007
  • Fundamental
  • Price
  • NSP $89.22
  • FOLD $8.16
  • Analyst Decision
  • NSP Hold
  • FOLD Strong Buy
  • Analyst Count
  • NSP 4
  • FOLD 9
  • Target Price
  • NSP $95.67
  • FOLD $17.00
  • AVG Volume (30 Days)
  • NSP 561.5K
  • FOLD 2.5M
  • Earning Date
  • NSP 04-30-2025
  • FOLD 05-08-2025
  • Dividend Yield
  • NSP 2.67%
  • FOLD N/A
  • EPS Growth
  • NSP N/A
  • FOLD N/A
  • EPS
  • NSP 2.39
  • FOLD N/A
  • Revenue
  • NSP $6,581,000,000.00
  • FOLD $528,294,999.00
  • Revenue This Year
  • NSP $5.91
  • FOLD $21.91
  • Revenue Next Year
  • NSP $7.79
  • FOLD $22.22
  • P/E Ratio
  • NSP $37.62
  • FOLD N/A
  • Revenue Growth
  • NSP 1.47
  • FOLD 32.29
  • 52 Week Low
  • NSP $68.79
  • FOLD $7.97
  • 52 Week High
  • NSP $109.80
  • FOLD $12.65
  • Technical
  • Relative Strength Index (RSI)
  • NSP 54.58
  • FOLD 30.82
  • Support Level
  • NSP $87.49
  • FOLD $8.40
  • Resistance Level
  • NSP $90.61
  • FOLD $8.62
  • Average True Range (ATR)
  • NSP 2.73
  • FOLD 0.24
  • MACD
  • NSP -0.31
  • FOLD -0.06
  • Stochastic Oscillator
  • NSP 73.01
  • FOLD 14.73

About NSP Insperity Inc.

Insperity Inc is a company that provides a wide range of human resources and business solutions designed to help businesses improve their performance. Small and midsize enterprises are the company's primary target customers. Majority of the company's products are offered through the company's Workforce Optimization and Workforce Synchronization solutions, which comprise various human resource functions, such as payroll and employment administration, employee benefits and compensation, government compliance, performance management, training and development services, and human capital management. The company generates all of its revenue in the United States.

About FOLD Amicus Therapeutics Inc.

Amicus Therapeutics Inc is a biotechnology company focused on discovering, developing and delivering medicines for people living with rare metabolic diseases. The company is engaged in developing a pipeline of medicines for rare metabolic diseases, including a rare disease gene therapy portfolio. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of advanced therapies to treat a range of devastating rare and orphan diseases.

Share on Social Networks: